Arteriosclerosis and Thrombosis, Vol 13, 1501-1504, Copyright © 1993 by American Heart Association

ARTICLES

Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain

CC Kuo, AM Gown, EP Benditt and JT Grayston
Department of Epidemiology, University of Washington, Seattle 98195.

Recent evidence has shown the presence of Chlamydia pneumoniae antigens and nucleic acid in coronary artery atheromas from autopsy patients in South Africa. In this study, the immunocytochemical technique was used to demonstrate C pneumoniae antigens in atheromas of the aorta in autopsy patients from retrospective aortic atherosclerosis studies at the University of Washington. The patients were 34 to 58 years old. Immunoperoxidase staining using Chlamydia-specific monoclonal antibodies showed one of four fatty streaks and six of 17 fibrous plaques were positive for C pneumoniae antigens; four control aortic tissues were negative. Two of the positive plaques were from the same patient. Double-label immunocytochemical staining using Chlamydia- and tissue type-specific monoclonal antibodies demonstrated the antigens in the cytoplasm of macrophages and smooth muscle cells in the atheromatous lesion. This study suggested a wider involvement of C pneumoniae organisms in atherosclerotic lesions of the arterial system than has previously been documented.

This article has been cited by other articles:

				Y. Naiki, R. Sorrentino, M. H. Wong, K. S. Michelsen, K. Shimada, S. Chen, A. Yilmaz, A. Slepenkin, N. W. J. Schroder, T. R. Crother, et al. TLR/MyD88 and Liver X Receptor {alpha} Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis J. Immunol., November 15, 2008; 181(10): 7176 - 7185. [Abstract] [Full Text] [PDF]

				S. P. Didion Chlamydophila pneumoniae and Endothelial Activation: The Smoke That Precedes the Fire of Atherosclerosis? Circ. Res., April 25, 2008; 102(8): 861 - 863. [Full Text] [PDF]

				S.-J. Jiang, C.-C. Kuo, M. W. Berry, A. W. Lee, and L. A. Campbell Identification and Characterization of Chlamydia pneumoniae-Specific Proteins That Activate Tumor Necrosis Factor Alpha Production in RAW 264.7 Murine Macrophages Infect. Immun., April 1, 2008; 76(4): 1558 - 1564. [Abstract] [Full Text] [PDF]

				A. Hasebe, N. D. Pennock, H.-H. Mu, F. V. Chan, M. L. Taylor, and B. C. Cole A Microbial TLR2 Agonist Imparts Macrophage-Activating Ability to Apolipoprotein A-1 J. Immunol., October 1, 2006; 177(7): 4826 - 4832. [Abstract] [Full Text] [PDF]

				A. Yilmaz, J. Weber, I. Cicha, C. Stumpf, M. Klein, D. Raithel, W. G. Daniel, and C. D. Garlichs Decrease in Circulating Myeloid Dendritic Cell Precursors in Coronary Artery Disease J. Am. Coll. Cardiol., July 4, 2006; 48(1): 70 - 80. [Abstract] [Full Text] [PDF]

				S. C. Johnston, H. Zhang, L. M. Messina, M. T. Lawton, and D. Dean Chlamydia pneumoniae Burden in Carotid Arteries Is Associated With Upregulation of Plaque Interleukin-6 and Elevated C-Reactive Protein in Serum Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2648 - 2653. [Abstract] [Full Text] [PDF]

				S G Baidya and Q-T Zeng Helper T cells and atherosclerosis: the cytokine web Postgrad. Med. J., December 1, 2005; 81(962): 746 - 752. [Abstract] [Full Text] [PDF]

				X. Yang, D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2308 - 2314. [Abstract] [Full Text] [PDF]

				K. Yaraei, L. A. Campbell, X. Zhu, W. C. Liles, C.-c. Kuo, and M. E. Rosenfeld Effect of Chlamydia pneumoniae on Cellular ATP Content in Mouse Macrophages: Role of Toll-Like Receptor 2 Infect. Immun., July 1, 2005; 73(7): 4323 - 4326. [Abstract] [Full Text] [PDF]

				M. P. Kim, M. Zhou, and L. M. Wahl Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture J. Leukoc. Biol., July 1, 2005; 78(1): 195 - 201. [Abstract] [Full Text] [PDF]

				G Arno, J C Kaski, D A Smith, J P Akiyu, S E Hughes, and C Baboonian Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques Heart, April 1, 2005; 91(4): 521 - 525. [Abstract] [Full Text] [PDF]

				M. P. Kim, C. A. Gaydos, B. J. Wood, J. P. Hardick, Y. Zhang, and L. M. Wahl Chlamydia pneumoniae Enhances Cytokine-Stimulated Human Monocyte Matrix Metalloproteinases through a Prostaglandin E2-Dependent Mechanism Infect. Immun., January 1, 2005; 73(1): 632 - 634. [Abstract] [Full Text] [PDF]

				L. L. Stoll, G. M. Denning, and N. L. Weintraub Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2227 - 2236. [Abstract] [Full Text] [PDF]

				J. S. Lindholt, J. Stovring, L. Ostergaard, S. Urbonavicius, E. W. Henneberg, B. Honore, and H. Vorum Serum Antibodies Against Chlamydia pneumoniae Outer Membrane Protein Cross-React With the Heavy Chain of Immunoglobulin in the Wall of Abdominal Aortic Aneurysms Circulation, May 4, 2004; 109(17): 2097 - 2102. [Abstract] [Full Text] [PDF]

				H. Kalvegren, M. Majeed, and T. Bengtsson Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease? Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1677 - 1683. [Abstract] [Full Text] [PDF]

				T-M Lin, W-j Chen, H-Y Chen, P-W Wang, and H-L Eng Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation J. Clin. Pathol., June 1, 2003; 56(6): 429 - 432. [Abstract] [Full Text] [PDF]

				F. Bea, M. H. Puolakkainen, T. McMillen, F. N. Hudson, N. Mackman, C. C. Kuo, L. A. Campbell, and M. E. Rosenfeld Chlamydia pneumoniae Induces Tissue Factor Expression in Mouse Macrophages via Activation of Egr-1 and the MEK-ERK1/2 Pathway Circ. Res., March 7, 2003; 92(4): 394 - 401. [Abstract] [Full Text] [PDF]

				E. Nordborg and C. Nordborg Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment Rheumatology, March 1, 2003; 42(3): 413 - 421. [Abstract] [Full Text] [PDF]

				C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis Eur. Heart J., January 2, 2003; 24(2): 198 - 208. [Abstract] [Full Text] [PDF]

				J. B. Sakash, G. I. Byrne, A. Lichtman, and P. Libby Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection Infect. Immun., July 1, 2002; 70(7): 3959 - 3961. [Abstract] [Full Text] [PDF]

				S. Lehto, L. Niskanen, M. Suhonen, T. Ronnemaa, P. Saikku, and M. Laakso Association Between Chlamydia pneumoniae Antibodies and Intimal Calcification in Femoral Arteries of Nondiabetic Patients Arch Intern Med, March 11, 2002; 162(5): 594 - 599. [Abstract] [Full Text] [PDF]

				R. Tavendale, D. Parratt, S.D. Pringle, R. A'brook, and H. Tunstall-Pedoe Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. The Scottish Heart Health Study Cohort Eur. Heart J., February 2, 2002; 23(4): 301 - 307. [Abstract] [Full Text] [PDF]

				J. Boman and M. R. Hammerschlag Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20. [Abstract] [Full Text]

				G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]

				B. Garner, D. J. Harvey, L. Royle, M. Frischmann, F. Nigon, M. J. Chapman, and P. M. Rudd Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of {alpha}-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles Glycobiology, October 1, 2001; 11(10): 791 - 802. [Abstract] [Full Text] [PDF]

				G. Caligiuri, M. Rottenberg, A. Nicoletti, H. Wigzell, and G. K. Hansson Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice Circulation, June 12, 2001; 103(23): 2834 - 2838. [Abstract] [Full Text] [PDF]

				A. Schumacher, A. B. Lerkerød, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals J. Clin. Microbiol., May 1, 2001; 39(5): 1859 - 1864. [Abstract] [Full Text]

				R. LaBiche, D. Koziol, T. C. Quinn, C. Gaydos, S. Azhar, G. Ketron, S. Sood, and T. J. DeGraba Presence of Chlamydia pneumoniae in Human Symptomatic and Asymptomatic Carotid Atherosclerotic Plaque Stroke, April 1, 2001; 32(4): 855 - 860. [Abstract] [Full Text] [PDF]

				A. Vink, M. Poppen, A. H. Schoneveld, P. J. M. Roholl, D. P. V. de Kleijn, C. Borst, and G. Pasterkamp Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual Circulation, March 27, 2001; 103(12): 1613 - 1617. [Abstract] [Full Text] [PDF]

				M. VALASSINA, L. MIGLIORINI, A. SANSONI, G. SANI, D. CORSARO, M. G. CUSI, P. E. VALENSIN, and C. CELLESI Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries J. Med. Microbiol., March 1, 2001; 50(3): 228 - 232. [Abstract] [Full Text] [PDF]

				P. Vehmaan-Kreula, M. Puolakkainen, M. Sarvas, H. G. Welgus, and P. T. Kovanen Chlamydia pneumoniae Proteins Induce Secretion of the 92-kDa Gelatinase by Human Monocyte- Derived Macrophages Arterioscler Thromb Vasc Biol, January 1, 2001; 21 (1): e1 - e8. [Abstract] [Full Text] [PDF]

				E. Blessing, S. Nagano, L. A. Campbell, M. E. Rosenfeld, and C.-c. Kuo Effect of Chlamydia trachomatis Infection on Atherosclerosis in Apolipoprotein E-Deficient Mice Infect. Immun., December 1, 2000; 68(12): 7195 - 7197. [Abstract] [Full Text] [PDF]

				A Meijer, P J M Roholl, S K Gielis-Proper, and J M Ossewaarde Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions J. Clin. Pathol., December 1, 2000; 53(12): 911 - 916. [Abstract] [Full Text] [PDF]

				K. Zibara, E. Chignier, C. Covacho, R. Poston, G. Canard, P. Hardy, and J. McGregor Modulation of Expression of Endothelial Intercellular Adhesion Molecule-1, Platelet-Endothelial Cell Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Aortic Arch Lesions of Apolipoprotein E-Deficient Compared With Wild-Type Mice Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2288 - 2296. [Abstract] [Full Text] [PDF]

				S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen Microorganisms in the aetiology of atherosclerosis J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654. [Abstract] [Full Text] [PDF]

				C.A Glader, J Boman, P Saikku, H Stenlund, L Weinehall, G Hallmanns, and G.H Dahlen The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae -specific IgG antibodies Eur. Heart J., April 2, 2000; 21(8): 639 - 646. [Abstract] [PDF]

				A. Shor and J. I. Phillips Chlamydia pneumoniae and Atherosclerosis JAMA, December 1, 1999; 282(21): 2071 - 2073. [Full Text] [PDF]

				A. Meijer, J. A. van der Vliet, P. J. M. Roholl, S. K. Gielis-Proper, A. de Vries, and J. M. Ossewaarde Chlamydia pneumoniae in Abdominal Aortic Aneurysms : Abundance of Membrane Components in the Absence of Heat Shock Protein 60 and DNA Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2680 - 2686. [Abstract] [Full Text] [PDF]

				C. A. Glader, B. Stegmayr, J. Boman, H. Stenlund, L. Weinehall, G. Hallmans, and G. H. Dahlen Chlamydia pneumoniae Antibodies and High Lipoprotein(a) Levels Do Not Predict Ischemic Cerebral Infarctions : Results From a Nested Case-Control Study in Northern Sweden Stroke, October 1, 1999; 30(10): 2013 - 2018. [Abstract] [Full Text] [PDF]

				J. T. Grayston Does Chlamydia pneumoniae Cause Atherosclerosis? Arch Surg, September 1, 1999; 134(9): 930 - 934. [Full Text] [PDF]

				B. K. Coombes and J. B. Mahony Chlamydia pneumoniae Infection of Human Endothelial Cells Induces Proliferation of Smooth Muscle Cells via an Endothelial Cell-Derived Soluble Factor(s) Infect. Immun., June 1, 1999; 67(6): 2909 - 2915. [Abstract] [Full Text] [PDF]

				M. Thomas, Y. Wong, D. Thomas, M. Ajaz, V. Tsang, P. J. Gallagher, and M. E. Ward Relation Between Direct Detection of Chlamydia pneumoniae DNA in Human Coronary Arteries at Postmortem Examination and Histological Severity (Stary Grading) of Associated Atherosclerotic Plaque Circulation, June 1, 1999; 99(21): 2733 - 2736. [Abstract] [Full Text] [PDF]

				R. E. Molestina, R. D. Miller, J. A. Ramirez, and J. T. Summersgill Infection of Human Endothelial Cells with Chlamydia pneumoniae Stimulates Transendothelial Migration of Neutrophils and Monocytes Infect. Immun., March 1, 1999; 67(3): 1323 - 1330. [Abstract] [Full Text] [PDF]

				Y-K Wong, P J Gallagher, and M E Ward Chlamydia pneumoniae and atherosclerosis Heart, March 1, 1999; 81(3): 232 - 238. [Abstract] [Full Text]

				M. E. Rottenberg, A. C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell Role of Innate and Adaptive Immunity in the Outcome of Primary Infection with Chlamydia pneumoniae, as Analyzed in Genetically Modified Mice J. Immunol., March 1, 1999; 162(5): 2829 - 2836. [Abstract] [Full Text] [PDF]

				M. V. Kalayoglu and G. I. Byrne A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial Lipopolysaccharide Infect. Immun., November 1, 1998; 66(11): 5067 - 5072. [Abstract] [Full Text] [PDF]

				M. Davidson, C.-C. Kuo, J. P. Middaugh, L. A. Campbell, S.-P. Wang, W. P. Newman III, J. C. Finley, and J. T. Grayston Confirmed Previous Infection With Chlamydia pneumoniae (TWAR) and Its Presence in Early Coronary Atherosclerosis Circulation, August 18, 1998; 98(7): 628 - 633. [Abstract] [Full Text] [PDF]

				E. M. Peterson, L. M. de la Maza, L. Brade, and H. Brade Characterization of a Neutralizing Monoclonal Antibody Directed at the Lipopolysaccharide of Chlamydia pneumoniae Infect. Immun., August 1, 1998; 66(8): 3848 - 3855. [Abstract] [Full Text] [PDF]

				J. U. Igietseme, L. L. Perry, G. A. Ananaba, I. M. Uriri, O. O. Ojior, S. N. Kumar, and H. D. Caldwell Chlamydial Infection in Inducible Nitric Oxide Synthase Knockout Mice Infect. Immun., April 1, 1998; 66(4): 1282 - 1286. [Abstract] [Full Text] [PDF]

				R. E. Molestina, D. Dean, R. D. Miller, J. A. Ramirez, and J. T. Summersgill Characterization of a Strain of Chlamydia pneumoniae Isolated from a Coronary Atheroma by Analysis of the omp1 Gene and Biological Activity in Human Endothelial Cells Infect. Immun., April 1, 1998; 66(4): 1370 - 1376. [Abstract] [Full Text] [PDF]

				K. Yamashita, K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa, and H. Ito Distribution of Chlamydia pneumoniae Infection in the Atherosclerotic Carotid Artery Stroke, April 1, 1998; 29(4): 773 - 778. [Abstract] [Full Text] [PDF]

				J. B. Muhlestein, J. L. Anderson, E. H. Hammond, L. Zhao, S. Trehan, E. P. Schwobe, and J. F. Carlquist Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model Circulation, February 24, 1998; 97(7): 633 - 636. [Abstract] [Full Text] [PDF]

				M. Maass, E. Krause, P.M. Engel, S. Kruger, and M. Maass Endovascular Presence of Chlamydia pneumoniae in Patients with Hemodynamically Effective Carotid Artery Stenosis Angiology, August 1, 1997; 48(8): 699 - 706. [Abstract] [PDF]

				H. Brade, W. Brabetz, L. Brade, O. Hoist, S. Lobau, M. Lucakova, U. Mamat, A. Rozalski, K. Zych, and P. Kosma Review: Chlamydial lipopolysaccharide Innate Immunity, February 1, 1997; 4(1): 67 - 84. [PDF]

				J. T. Grayston, C.-c. Kuo, A. S. Coulson, L. A. Campbell, R. D. Lawrence, M. J. Lee, E. D. Strandness, and S.-p. Wang Chlamydia pneumoniae (TWAR) in Atherosclerosis of the Carotid Artery Circulation, December 15, 1995; 92(12): 3397 - 3400. [Abstract] [Full Text]

				S. Sasu, D. LaVerda, N. Qureshi, D. T. Golenbock, and D. Beasley Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 Stimulate Proliferation of Human Vascular Smooth Muscle Cells via Toll-Like Receptor 4 and p44/p42 Mitogen-Activated Protein Kinase Activation Circ. Res., August 3, 2001; 89(3): 244 - 250. [Abstract] [Full Text] [PDF]

				E. Blessing, C.-c. Kuo, T.-M. Lin, L. A. Campbell, F. Bea, B. Chesebro, and M. E. Rosenfeld Foam Cell Formation Inhibits Growth of Chlamydia pneumoniae but Does Not Attenuate Chlamydia pneumoniae-Induced Secretion of Proinflammatory Cytokines Circulation, April 23, 2002; 105(16): 1976 - 1982. [Abstract] [Full Text] [PDF]